Sculpting Success: The Importance of Diet and Physical Activity to Support Skeletal Muscle Health during Weight Loss with New Generation Anti-Obesity Medications.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing broader clinical trial literature to offer clinical recommendations without systematic methodology or primary human data.
PubMed 39624804 · doi:10.1016/j.cdnut.2024.104486
What was done
This narrative review synthesized evidence from large-scale clinical weight loss, diet, and exercise trials to establish recommendations for protecting skeletal muscle mass in patients taking new-generation anti-obesity medications (AOMs).
What was found
The authors report that fat-free mass (including skeletal muscle) accounts for 20% to 50% of total weight loss achieved with new-generation AOMs. Over 12 to 18 months, this equates to approximately 6 kg or 10% of total lean mass lost, an amount comparable to roughly a decade of human aging. Due to a scarcity of dedicated studies testing diet and exercise protocols specifically paired with AOMs, recommendations for high-protein diets and regular resistance training were extrapolated from the broader weight loss literature.
Why it matters
Highlights the magnitude of lean tissue loss during pharmacologically induced weight loss and makes the clinical case for pairing AOM prescriptions with resistance training and nutritional support.
Limits
The paper is a narrative review providing expert commentary without a systematic search protocol or primary trial data. Direct empirical evidence evaluating specific diet and physical activity protocols in individuals concurrently using modern AOMs remains largely absent.
Cited by
- supports During weight loss diets without resistance training and adequate protein, up to 40% of the total weight lost can come from lean mass.